The Safe Anaesthesia Liaison Group has announced the fourth round of its exciting programme of fellowships for anaesthetists interested in patient safety.
In collaboration with the Association of Anaesthetists and the Royal College of Anaesthetists, the Safe Anaesthesia Liaison Group (SALG) are offering a unique programme of formal training through Harvard Medical School that aims to develop international expertise in peri-operative quality and safety.
The successful candidates will be known as the SALG-BIDMC Safety Scholars, and will be provided with:
- A fully funded place in a Master of Healthcare Quality and Safety (MHQS) course from Harvard University, while also engaged in clinical practice at a suitable level at the Beth Israel Deconess Medical Center (BIDMC), a major Harvard Medical School teaching hospital with a long tradition of clinical, academic and research excellence in Boston’s highly competitive healthcare environment.
- Co-mentorship from the Vice Chair of Quality and Safety at BIDMC (Professor SK Ramachandran), and the SALG co-chairs: Professor J J Pandit and Dr P Young
- Scholars will identify project(s) in the UK that they will develop and lead on, after their return to the UK
By accessing oversight from these faculty, this scholarship will equip successful candidates with the theoretical, practical and leadership skills to implement quality and safety techniques and processes within their organizations, in addition to benefitting from the immense network and resources of the Harvard academic community. We expect that they will be positioned to become the future leaders in quality and safety.
Information on how to apply are here
The deadline for applications to be received no later than noon Monday 19 September 2022. Interviews (online) will be held Thursday or Friday 29 or 30 September 2022.
Successful Fellow/trainee candidates will commence their program on 1 July 2023 or 2024, depending on the completion of necessary paperwork including, but not limited to visa and medical license processes. Successful Staff/consultant candidates will commence the clinical part of their position as soon as all the necessary milestones are achieved and join the Master program cohort on the next 1 July. Accordingly, candidates are encouraged to apply and plan early and actively participate in the preparatory processes as soon as they are selected for interview.
Interested candidates should:
• complete the preliminary visa and regulatory screening form which can be found below
• submit a letter of intent explaining their reasons for applying
• submit a full CV including publication list, h-index and any grant funding obtained in the course of their career
• provide three references, which should be included in the body of the application on headed notepaper and signed by each referee
• if a trainee, should provide a statement from current employer that they guarantee that you will be employed with them on completion of your scholarship
• submit all of the above as a single file (Word, or preferably pdf) by the closing date. The filename should be the candidate’s surname, followed by ‘BIDMC’ (eg, Smith-BIDMC). Email the single file to [email protected]
(Note: the timelines for the application process, and future start dates may be disrupted by any ongoing coronavirus issues. Equally we appreciate potential candidates may find their proposals disrupted for reasons beyond their control. We intend to be as flexible as possible in handling the process and applications this year).